An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging ; volume:8 ; number:1 ; day:15 ; month:3 ; year:2018 ; pages:1-15 ; date:12.2018
Scientific reports ; 8, Heft 1 (15.3.2018), 1-15, 12.2018
- Urheber
-
Wang, Xueying
- Beteiligte Personen und Organisationen
-
Kastanenka, Ksenia V.
Arbel-Ornath, Michal
Commins, Caitlin
Kuzuya, Akira
Lariviere, Amanda J.
Krafft, Grant A.
Hefti, Franz
Jerecic, Jasna
Bacskai, Brian J.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-22979-2
- URN
-
urn:nbn:de:1111-201805144533
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Xueying
- Kastanenka, Ksenia V.
- Arbel-Ornath, Michal
- Commins, Caitlin
- Kuzuya, Akira
- Lariviere, Amanda J.
- Krafft, Grant A.
- Hefti, Franz
- Jerecic, Jasna
- Bacskai, Brian J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stability of single and double layer fibrillar amyloid-β oligomers
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Origins of amyloid-β
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selective amyloid-β lowering agents
Beta-amyloid oligomers: recent developments
Stability of single and double layer fibrillar amyloid-β oligomers
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Origins of amyloid-β
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selective amyloid-β lowering agents
Beta-amyloid oligomers: recent developments
Stability of single and double layer fibrillar amyloid-β oligomers
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Origins of amyloid-β
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selective amyloid-β lowering agents